The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Kemik, Ozgur ^a   Sumer, Aziz ^a   Kemik, Ahu S ^b   Hasirci, Ismail ^a   Purisa, Sevim ^c   Dulger, Ahmet C ^a   Demiriz, Baris ^d   Tuzun, Sefa ^e  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Dr Zekai Tahir Burak Women Health Education and Research Hospital   (Turkey)

^e Haseki Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ADIPONECTIN; ALBUMIN; C REACTIVE PROTEIN; CYTOKINE; GHRELIN; HORMONE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MIDKINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN C; TUMOR MARKER;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER PATIENT; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION; BLOOD; COLON TUMOR; COLORIMETRY; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PHOTOMETRY; PROGNOSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; CACHEXIA; COLONIC NEOPLASMS; COLORIMETRY; CYTOKINES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HORMONES; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 77957122875     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-85     Document Type: Article

References (49)

1. Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J Clin 2007, 57:225 241. 10.3322/canjclin.57.4.225, 17626119.
2. Polesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinalcancer. Dig Dis 2003, 21:198-213. 10.1159/000073337, 14571093.
3. Chamberlain JS. Cachexia in cancer-zeroing in onmyosin. N Engl J Med 2004, 351:2124-2125. 10.1056/NEJMcibr042889, 15537911.
4. Rubin H. Cancer cachexia: its correlations andcauses. Proc Natl Acad Sci USA 2003, 100:5384-5389. 10.1073/pnas.0931260100, 154354, 12702753.
5. Boddeart MS, Gerritsen WR, Pinedo HM. On our own way to targeted therapy for cachexia incancer. Curr Opin Oncol 2006, 18:335-340. 10.1097/01.cco.0000228738.85626.ac, 16721127.
6. Saini A, Al-Shants N, Stework CE. Waste management cytokines growth factors and cachexia. Cytokine Growth factor Rev 2006, 17:475-486. 10.1016/j.cytogfr.2006.09.006, 17118696.
7. Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr metab care 2005, 8:265-269. 10.1097/01.mco.0000165004.93707.88, 15809528.
8. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal muscle geneproducts. J Clin Invest 2004, 114:370-8. 484974, 15286803.
9. Ramas EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Nutr Metab care 2004, 7:427-434.
10. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Banas T. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-α, VEGF-A, VEGF-C and midkine in gastroesophageal cancerpatients. Clin Biochem 2007, 40:1353-1360. 10.1016/j.clinbiochem.2007.07.013, 17931612.
11. Have PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001, 226:963-977.
12. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin andresistin. Clin Chem 2004, 50:1511-1525. 10.1373/clinchem.2004.032482, 15265818.
13. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in humandisease. Eur J Endocrinol 2003, 148:293-300. 10.1530/eje.0.1480293, 12611609.
14. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of on adipose-specific protein, adiponectin, inobesity. Biochem Biophys Res Commun 1999, 257:79-83. 10.1006/bbrc.1999.0255, 10092513.
15. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, Häring HU, Stumvoll M. Relationship of serum adiponectin and leptin concentrations with body fat distribution inhumans. Obes Res 2003, 11:368-72. 10.1038/oby.2003.48, 12634431.
16. Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, De Giacomo P, Giorgino R, De Pergola G. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced non-oxidative glucosemetabolism. J Clin Endocrinol Metab 2003, 88:1748-1752. 10.1210/jc.2002-021215, 12679468.
17. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol metab 2001, 86:3815-19. 10.1210/jc.86.8.3815, 11502817.
18. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, antzoros CS, La Vecchia C. Circulation adiponectin and endometrial cancerrisk. J Clin Endocrinol Metab 2004, 89:1160-1163. 10.1210/jc.2003-031716, 15001602.
19. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. Association of serum adiponectin levels with breast cancerrisk. Clin Cancer Res 2003, 9:5699-5704.
20. Ishikawa M, Kitayoma J, Kazoma S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastriccancer. Clin Cancer Res 2005, 11:466-472. 10.1158/1078-0432.CCR-04-1453, 15701829.
21. Wang B, Jenkins JR, Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: Integrated response to TNF-α. Am J Physiol Endocrinol Metab 2005, 288:E731-E740. 10.1152/ajpendo.00475.2004, 15562246.
22. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide fromstomach. Nature 1999, 402:656-660. 10.1038/45230, 10604470.
23. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K. Ghrelin strongly stimulates growth hormone release inhumans. J Clin Endocrinol Metab 2000, 85:4908-11. 10.1210/jc.85.12.4908, 11134161.
24. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 409:194-8. 10.1038/35051587, 11196643.
25. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschöp M. Weight gain decreases elevated plasma ghrelin concentrations of patients with an anorexianervosa. Eur J Endocrinol 2001, 145:669-73. 10.1530/eje.0.1450669, 11720888.
26. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H, Kojima M, Kangawa K, Kohno N. Increased plasma ghrelin levels in lung cancercachexia. Clin Cancer Res 2003, 9:774-8.
27. Garcia JM, Garcia-Toyza M, Hijazi RA, Taffet G, Epner D, Mann D, Smith RG, Cunningham GR, Marcelli M. Active ghrelin levels and active/total ghrelin ratio in cancer-inducedcachexia. J Clin Endocrinol Metab 2005, 90:2920-2926. 10.1210/jc.2004-1788, 15713718.
28. Brichard SM, Delporte MI, Lambert M. Adipocytokines in cachexia nervosa: a review focusing on leptin and adiponectin. Horm Metab res 2003, 35:337-342. 10.1055/s-2003-41353, 12920654.
29. Brown DR, Beikowitz DE, Breslow MJ. Weight loss is not associated with hyperleptinemia in humans with pancreaticcancer. J Clin Endocrinol Metab 2001, 86:162-166. 10.1210/jc.86.1.162, 11231995.
30. Bolukbas FF, Ki{dotless}li{dotless}c H, Bolukbas C, Gumus M, Horoz M, Turhal NS, Kavakli B. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004, 4:29. 10.1186/1471-2407-4-29, 459225, 15217519.
31. Lelbach A, Muzes G, Feher J. Current perspectives of catabolic mediators of cancer cachexia. Med Sci Monit 2007, 13:RA168-173.
32. Fleming JD, Cooper JS, Henson DE. American Joint Committee on Cancer Staing Manual. 1997, Philadelphia: Lippincott. Raven, 5.
33. Sanz R, Ovejero VJ, Gonzalez JJ, et al. Mortality risk scales in esophagoctomy for cancer: their usefulness in preoperative patientselection. Hepatogastroenterology 2006, 53:869-873.
34. Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, Cervera E, Mohar-Betancourt A. Serum albumin as a significant prognostic factor for patients with gastriccarcinoma. Ann Surg Oncol 2007, 14:381-389. 10.1245/s10434-006-9093-x, 17160496.
35. Gockel I, Dirksen K, Messow CM, Iunginger T. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Gastroenterol 2006, 12(37):46-50.
36. Nozoe T, Saeki H, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophagealcarcinoma. Am J Surg 2001, 182:197-201. 10.1016/S0002-9610(01)00684-5, 11574097.
37. Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-esophagealcancer. Br J Cancer 2006, 94:1568-71. 2361311, 16685271.
38. Beecken WD, Kramer W, Jonas D. New molecular mediators in tumorangiogenesis. J Cell Mol Med 2000, 4:262-269. 10.1111/j.1582-4934.2000.tb00125.x, 12067460.
39. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Konieczny D, Kustrzeba-Wojcicka I, Terlecki G, Banas T. Elevation of circulating IL-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas-implication for clinical evaluation of cancer patient. Cytokine 2008, 3:232-9.
40. Boedefeld WM, Bland KI, Heslin MJ. Recent insights into angiogenesis, apoptosis, invasion and metastasis in colorectal carcinoma. Ann Surg Oncol 2003, 10:839-851. 10.1245/ASO.2003.02.021, 14527901.
41. Macías I, García-Pérez S, Ruiz-Tudela M, Medina F, Chozas N, Girón-González JA. Modification of pro-and anti-inflammatory cytokines and vascular-related molecules by tumor necrosis factor-α blockade in patients with rheumatoidarthritis. J Rheumatol 2005, 32:2102-8.
42. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation andtumorigenesis. J Biochem 2002, 132:359-371.
43. Ikematsu S, Yano A, Aridome K, Kikuchi M, Kumai H, Nagano H, et al. Serum midkine levels are increased in patients with various type ofcarcinomas. Br J Cancer 2000, 83:701-706. 10.1054/bjoc.2000.1339, 2363529, 10952771.
44. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipidmetabolism. Trends Endocrinol Metab 2002, 13:84-89. 10.1016/S1043-2760(01)00524-0, 11854024.
45. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003, 285:E527-E533.
46. Jamieson NB, Brown DJ, Michael Wallace A, McMillan DC. Adiponectin and the systemic inflammatory response in weight-losing patients with nonsmall cell lungcancer. Cytokine 2004, 27:90-92. 10.1016/j.cyto.2004.03.017, 15242698.
47. Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf) 2004, 61:332-338. 10.1111/j.1365-2265.2004.02101.x, 15355449.
48. Dulger H, Alici S, Sekeroglu MR, Erkog R, Ozbek H, Noyan T, Yavuz M. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinalcancer. Int J Clin Pract 2004, 58:545-549. 10.1111/j.1368-5031.2004.00149.x, 15311551.
49. Simons JP, Schols AM, Campfield LA, Wouters EF, Sanis WH. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond) 1997, 93:273-277.